Tecan stock reports higher adjusted EBITDA margin in H1 2026
Published on 09/29/2026 at 09:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Tecan (ISIN CH0012100191) stock was trading at CHF 232.20 on the SIX Swiss Exchange on September 29, 2026 at 9:19 a.m. CEST, up 0.87 percent from the prior close of CHF 230.20. The latest operating picture combines modest reported sales pressure with improving adjusted profitability, according to Yahoo Finance in its transcript of the August 11, 2026 H1 results call.
Sales growth stays positive locally
Tecan reported H1 2026 sales of CHF 427.5 million, a 2.7 percent decline in reported currency but a 3.4 percent increase in local currencies. Order entry reached CHF 444.3 million, up 3.0 percent in local currencies, and the book-to-bill ratio was 1.04, according to Yahoo Finance.
The split between sales and orders matters for the stock because it shows demand running ahead of recognized revenue during the first half. Tecan said life sciences sales rose 3.1 percent in local currencies, while partnering sales increased 3.6 percent, with second-quarter growth improving in both areas.
Margin guidance supports the recovery case
Adjusted EBITDA was CHF 64.5 million, with an adjusted EBITDA margin of 15.1 percent versus 15.0 percent in H1 2025. The company also reported CHF 12.3 million in net profit and adjusted net profit of CHF 32.5 million, down 3.5 percent year over year, according to Yahoo Finance.
For fiscal year 2026, Tecan maintained adjusted EBITDA margin guidance of 15.5 percent to 16.5 percent and said it expects to finish toward the upper end of that range. The margin improvement is material for investors because the Rewired transformation program is intended to lift efficiency while the company continues to manage foreign exchange, tariffs and investment costs.
Stock trades near its yearly high
Tecan's September 29, 2026 market capitalization was CHF 2.9 billion, with a 52-week range of CHF 110.60 to CHF 233.60 and volume of 2,974 shares. The reference price of CHF 232.20 stood CHF 1.40 below the 52-week high, placing the stock close to its upper yearly boundary while the daily gain remained below the 1.00 percent threshold for a stronger price-move headline.
At the latest price, the market is weighing the 3.4 percent local-currency sales increase against the 2.7 percent reported decline and the 15.1 percent adjusted EBITDA margin. Tecan's next strategic test is execution: the company targets CHF 1.0 billion in sales and a 20.0 percent adjusted EBITDA margin for 2028, according to Yahoo Finance.
CHF 232.20 keeps Tecan near its high
Tecan stock was last at CHF 232.20 on the SIX Swiss Exchange on September 29, 2026 at 9:19 a.m. CEST, with a market capitalization of CHF 2.9 billion and a 52-week high of CHF 233.60.
Tecan stock key data
- Company: Tecan Group AG
- ISIN: CH0012100191
- Ticker: TECN
- Trading venue: SIX Swiss Exchange
- Price (as of September 29, 2026, 9:19 a.m. CEST): CHF 232.20
- Market capitalization: CHF 2.9 billion (as of September 29, 2026)
- 52-week range: CHF 110.60-233.60 (as of September 29, 2026)
- Sector / Industry: Healthcare / Medical instruments and supplies
